Free Trial

agilon health, inc. (NYSE:AGL) Shares Sold by Rock Springs Capital Management LP

agilon health logo with Medical background

Rock Springs Capital Management LP decreased its holdings in shares of agilon health, inc. (NYSE:AGL - Free Report) by 18.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,463,300 shares of the company's stock after selling 1,633,500 shares during the quarter. Rock Springs Capital Management LP owned about 1.81% of agilon health worth $14,180,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of AGL. MetLife Investment Management LLC boosted its stake in agilon health by 4.0% during the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company's stock worth $332,000 after buying an additional 6,762 shares during the period. Dimensional Fund Advisors LP raised its position in agilon health by 25.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 255,914 shares of the company's stock worth $486,000 after purchasing an additional 51,852 shares during the period. Capital International Investors boosted its position in shares of agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock valued at $42,431,000 after buying an additional 9,346,295 shares during the period. Canada Pension Plan Investment Board purchased a new stake in shares of agilon health in the fourth quarter worth approximately $191,000. Finally, Raymond James Financial Inc. purchased a new stake in shares of agilon health in the fourth quarter worth approximately $33,000.

agilon health Stock Performance

Shares of NYSE AGL traded up $0.07 during trading on Friday, reaching $3.89. 3,612,723 shares of the company traded hands, compared to its average volume of 4,830,383. The stock has a market cap of $1.61 billion, a P/E ratio of -4.14 and a beta of 0.38. The firm's fifty day simple moving average is $4.19 and its 200 day simple moving average is $3.14. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $7.73.

Analysts Set New Price Targets

A number of equities analysts have commented on AGL shares. Sanford C. Bernstein upgraded shares of agilon health from a "market perform" rating to an "outperform" rating and upped their target price for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a report on Friday, March 21st. Stifel Nicolaus lifted their price objective on agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a report on Wednesday, February 26th. Cowen reissued a "hold" rating on shares of agilon health in a research report on Tuesday, April 15th. Finally, Robert W. Baird dropped their price objective on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $4.81.

Check Out Our Latest Stock Report on AGL

About agilon health

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

See Also

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines